spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Increlex 

 HSMN NewsFeed - 14 Jan 2014
Ipsen to set up its own US oncology team for Somatuline(R) Depot(R) (lanreotide) Injection in neuroendocrine tumors
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Oct 2009
Ipsen Announces the Launch of Dysport(R) (abobotulinumtoxinA) in the United States for the Treatment of Cervical Dystonia
Biopharmaceuticals
 HSMN NewsFeed - 25 Feb 2009
Proteolix Announces the Appointment of John Scarlett, M.D., President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jun 2008
Tercica Announces Results from Increlex(R) IGFD Patient Registry and Other Increlex(R) Studies at the 90th Meeting of the Endocrine Society
Biopharmaceuticals
 HSMN NewsFeed - 31 Aug 2007
Ipsen: Somatuline(R) Depot Receives Marketing Approval in the United States for the Treatment of Acromegaly
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 9 Aug 2007
IPSEN: Increlex(R) Receives Marketing Authorisation in the European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 8 Aug 2007
Tercica Receives Marketing Approval for Increlex in the European Union
Biopharmaceuticals Endocrinology Regulatory
 HSMN NewsFeed - 10 Jul 2007
Tercica Announces Agreement with Genentech for Worldwide Growth Hormone and IGF-1 Combination Product Development and Commercialization
Biopharmaceuticals
 HSMN NewsFeed - 25 May 2007
Ipsen: Increlex(R) Receives CHMP Positive Opinion for the Treatment of Severe Primary IGF-1 Deficiency
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 16 May 2007
Tercica Announces New Manufacturing Agreement with Lonza
Biopharmaceuticals
 HSMN NewsFeed - 6 Mar 2007
Litigation Settlement Reached Between Tercica, Genentech and Insmed
Biopharmaceuticals Litigation
 HSMN NewsFeed - 6 Dec 2006
Jury Finds Insmed Infringed Patents Owned By Genentech And Exclusively Licensed to Tercica
Biopharmaceuticals Litigation
 HSMN NewsFeed - 16 Oct 2006
Insmed Sues Tercica for False Advertising
Biopharmaceuticals Litigation
 HSMN NewsFeed - 16 Oct 2006
Ipsen and Tercica Complete Worldwide Strategic Collaboration Agreement in Endocrinology
Biopharmaceuticals Endocrinology Licensing
 HSMN NewsFeed - 5 Jul 2006
Court Rules Insmed Infringes Tercica IGF-1 Process Patent
Biopharmaceuticals Litigation
Return to NewsFeed  

 Additional items found! 16

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 16 additional stories matching:
Increlex
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.